Picture of DIAGNOSTIC MEDICAL SYSTEMS SA logo

ALDMS — DIAGNOSTIC MEDICAL SYSTEMS SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: DMS Group Reports Encouraging First Results Of The Clinical Trial On Osteoarthritis

Jan 11 (Reuters) - DIAGNOSTIC MEDICAL SYSTEMS SA  DMSP.PA :
    * FIRST ENCOURAGING RESULTS OF THE CLINICAL TRIAL ON
OSTEOARTHRITIS
    * TREATMENT TECHNIQUE IS FAST, MINIMALLY INVASIVE AND
APPRECIATED
BY PATIENTS
    * 12-MONTH FOLLOW-UP VISITS ARE CURRENTLY UNDERWAY
    * EFFECTIVENESS OF TREATMENT  AND DURATION OF ITS EFFECT
APPEAR
SUPERIOR TO HYALURONIC ACID
    * INTERMEDIATE AND FINAL RESULTS WILL BE COMMUNICATED DURING
Q2
2019
    * IF FINAL RESULTS CONFIRM MAINTENANCE OF EFFECT ONE YEAR
AFTER
TREATMENT, WITHOUT HAVING TO REPEAT THE INJECTIONS, IT COULD
REPRESENT ALTERNATIVE TO INJECTIONS OF HYALURONIC ACIDS AND
DELAY OR POSSIBLY REPLACE THE USE OF A PROSTHESIS

Source text for Eikon:  ID:nACT56676 
Further company coverage:  DMSP.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on DIAGNOSTIC MEDICAL SYSTEMS SA

See all news